Physician profile
Gary C Lee
NPI 1073633467
$1,292.19
in general payments reported to CMS, 2019-2025
11 companies · $74.42 in 2025
The $74.42 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $319 · 2020: $81.69 · 2021: $138 · 2022: $131 · 2023: $293 · 2024: $255 · 2025: $74.42.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $622.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $489.45 | 2019-2025 | |
| Janssen Biotech, INC. | $280.94 | 2019-2024 | Tremfya, Simponi, Simponi Aria |
| Abbvie INC. | $228.05 | 2019-2024 | |
| Lilly USA, LLC | $63.40 | 2019-2024 | Taltz, Olumiant |
| Merck Sharp & Dohme LLC | $49.69 | 2019 | |
| Taro Pharmaceuticals USA, INC. | $44.44 | 2019 | |
| Galderma Laboratories, L.P. | $43.51 | 2023 | |
| Amgen INC. | $31.14 | 2023 | Otezla |
| Genzyme Corporation | $24.94 | 2020 | |
| Sanofi-Aventis U.S. LLC | $21.88 | 2021 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.